Shelley D. Spray - 24 Nov 2021 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
24 Nov 2021
Net transactions value
$0
Form type
4
Filing time
29 Nov 2021, 15:06:41 UTC
Next filing
23 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Award $0 +32,500 $0.000000 32,500 24 Nov 2021 Common Stock 32,500 $21.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third (1/3) of the shares subject to the option will vest on November 24, 2022, and the remaining shares will vest in equal monthly installments thereafter over the following two-year period, subject to the Reporting Person's continued service through each vesting date.